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Summary
Nuclear factor kappa B (NF-kB) is a key regulator of
the immune response, but in almost the same manner
it is involved in induction of inﬂammation, prolifera-
tion and regulation of apoptosis. In the central
nervous system activated NF-kB plays a neuroprotec-
tive role. While in some neurodegenerative disorders
the role of NF-kB is well characterized, there is poor
knowledge on the role of NF-kB in prion disease. We
found binding but no transcriptional activity of the
transcription factor in vitro. Characterizing the
mechanism of cell death after infection with patho-
logical prion protein increased caspase-9 and
caspase-3 activity was detected and the lack of NF-kB
activity resulted in the inability to activate target
genes that usually play an important role in
neuroprotection. Additionally, we investigated the
role of NF-kB after prion infection of Nfkb1–/–, Nfkb2–/–
and Bcl3–/– mice and central nervous system-speciﬁc
p65-deleted mice revealing an accelerated prion
disease in NF-kB2- and Bcl-3-deﬁcient mice, which is
in line with a reduced neuroprotective activity in prion
infection. Based on our ﬁndings, we propose a model
whereby the alteration of NF-kB activity at the early
stages of infection with pathological prion protein
leads to neuronal cell death mediated by mitochon-
drial apoptosis.
Introduction
Prion diseases represent a group of lethal neurodegen-
erative disorders, associated with the conversion of the
cellular protein PrPc into an abnormally folded isoform,
PrPSc. The accumulation of the misfolded protein and the
associated extensive neuronal cell loss result in degen-
erative alterations of the brain as represented by an
extensive vacuolation. This is characteristic for transmis-
sible spongiform encephalopathies (TSE) in human and
animals. The neuronal cell death in prion disease was
described as an apoptotic process (Hetz et al., 2003;
Cronier et al., 2004). However, the signal pathway from
the recognition of the pathological agent by the host cell to
the nuclear events preceding cell death is not completely
understood. The activation of the effector caspase-3 rep-
resents a main event in apoptotic processes. This can
occur directly upon auto-processing of caspase-8 to its
active form after recruitment of death receptors. Another,
indirect pathway involves the release of death-promoting
factors like cytochrome c from the mitochondria. Here, the
Bcl-2 family of proteins contains positive (Bax, Bak, Bcl-xs,
Bad, Bid) and negative regulators (Bcl-2, Bcl-xL, Bcl-w) of
apoptosis at the mitochondrial level. Both pathways have
been described in neurodestructive processes (reviewed
in Polster and Fiskum, 2004).
The transcription factor NF-kB plays a central role in the
regulation of a large variety of cellular events. Apart from
its function as regulator of the expression of inﬂammatory
cytokines, chemokines, immunoreceptors and adhesion
molecules, it inﬂuences apoptosis in several cell types
(reviewed in: Pahl, 1999; Karin and Lin, 2002). Nuclear
factor kappa B (NF-kB) represents dimeric transcription
factors that belong to the Rel family, which encompass
ﬁve members: NF-kB1 (p105/p50), NF-kB2 (p100/p52),
RelA (p65), RelB and c-Rel. Dimers containing RelA,
RelB or c-Rel are transcriptional activators whereas
homodimers of p50 and p52, which are devoid of a
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non-stimulated cells, NF-kB is sequestered in an inactive
form in the cytoplasm by the inhibitor of kappaB (IkB).
After successive phosphorylation and degradation of IkB,
NF-kB translocates to the nucleus and exerts its biological
function (reviewed in Bonizzi and Karin, 2004). In the
brain NF-kB is an important regulator of biochemical and
molecular cascades that can either prevent cell death and
promote neuronal plasticity or induce apoptosis. NF-kBi s
activated by various intercellular signals including cytok-
ines, neurotrophic factors and neurotransmitters.
Depending on the cell type the same signal can either
induce or prevent apoptosis (Mattson et al., 2000). In
addition, alteration of NF-kB activity may represent an
important mechanism for inducing or enhancing apoptosis
(Barkett et al., 1997; Mattson et al., 1997). Concerning
neuronal cell death, considerable evidence has been pre-
sented that NF-kB induces the expression of anti-
apoptotic gene products (Mattson et al., 2000; Bhakar
et al., 2002). NF-kB was proposed to protect neurons
temporarily from the amyloid b-mediated apoptosis
leading to neurodegeneration during Alzheimer’s disease
(Kaltschmidt et al., 1999). Nevertheless, in a mouse
model of stroke NF-kB activation enhances neuronal
death, where the activation of IKK plays an essential role
(Herrmann et al., 2005). In prion diseases very little is
known on the role of NF-kB concerning neuropathology.
An enhanced NF-kB activity has been described in the
brain of scrapie-infected mice (Kim et al., 1999). Further-
more, the synthetic peptide of the prion protein PrP 106–
126 activates NF-kB in microglial cells (Fabrizi et al.,
2001). In order to elucidate the role of NF-kB in prion
infection, we addressed the question whether NF-kB
activity is altered after acute infection with the pathological
prion protein in a neuroblastoma cell line (Bos2 cells)
(Bosque and Prusiner, 2000), and in the mouse model of
prion infection. In particular, we were interested in the
mechanism of neuronal cell death early after infection with
the pathological prion protein. We found an enhanced
NF-kB binding activity in infected Bos2 cells, whereas no
activation of a NF-kB reporter was observed. Further-
more, we were able to demonstrate an involvement of
mitochondria in apoptosis induced early after prion
infection. In order to generalize our in vitro ﬁndings, we
also investigated the role of NF-kB in vivo after prion
infection of Nfkb1–/–, Nfkb2–/– and Bcl3–/– mice and a
mouse strain, where p65 (RelA) was deleted in the central
nervous system (CNS). After intracerebral infection, the
Nfkb2–/– and Bcl3–/– animals appeared to be more sensi-
tive to prion infection and died at an earlier time point
compared with wild-type control mice. We hypothesize a
loss of protective function of NF-kB in the context of prion
disease and propose a possible mechanism where anti-
apoptotic genes like BclxL are downregulated.
Results
NF-kB binding but no transcriptional activity induced
by PrPSc
The highly PrPSc-susceptible subclone of the N2A neuro-
blastoma cell line (Bos2) (Bosque and Prusiner, 2000)
was used for infection with PrPSc scrapie strain RML6. Our
study was focused on the use of PrPSc from mouse brain.
Therefore, a 0.2% brain homogenate of terminally sick
PrPSc-infected CD1 mice were used for infection. As con-
trols, cells were treated with a non-infected brain homo-
genate (CD1) with equal concentrations. The dilution of
brain homogenate used for either in vitro or in vivo infec-
tion was improbably sufficient to induce an unspeciﬁc
response mediated by factors present in the brain (e.g.
cytokines) (Brown et al., 2003). After acute PrPSc inocula-
tion of Bos2 cells infection was controlled by cell blot
technique as described in Experimental procedures for
each experiment (data not shown). To determine DNA
binding activity of NF-kB after prion infection, the cell
nuclei of PrPSc-infected and control cells were isolated
and tested in an electromobility shift assay (EMSA). An
increase of NF-kB binding was found as early as 1 day
after incubation with RML6 compared with cells treated
with non-infected brain homogenate and compared with
untreated Bos2 cells (Fig. 1A). Enhanced NF-kB binding
was also found after tumour necrosis factor (TNF)-a
treatment. This DNA/protein complex disappeared after
competition with a 50-fold excess of non-radioactive
NF-kB/DNA probe but not with a mutant probe. This
control demonstrates the speciﬁcity of the signal on the
autoradiography. Taken together, these results indicate
that RML6 infection induces NF-kB binding activity in
Bos2 cells above background levels of normal brain
homogenate.
To elucidate the transcriptional activity of NF-kB,
luciferase reporter gene assays were performed. There-
fore, Bos2 cells were transiently transfected with a
kB-responsive reporter construct and 6 h later cells were
infected with RML6. After an incubation period of 20 h the
cells were lysed and the cell extracts were used for
luciferase activity measurement. No activation was found
after incubation of Bos2 cells with RML6 compared with
CD1-treated or -untreated control cells. However, NF-kB
transcriptional activity was observed when Bos2 cells
were treated with TNF-a as a positive control (Fig. 1C).
These data indicate that the NF-kB binding complex
induced by RML6 is not transcriptionally active in Bos2
cells.
To further characterize the nature of the NF-kB dimers
presented in the nucleus after acute PrPSc infec-
tion, precipitations of kB binding proteins with an
agarose-conjugated consensus kB oligonucleotide were
performed and the precipitates were analysed by Western
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control and TNF-a-treated cells, almost no signal for p65
was found after RML6 infection. In contrast, p50, Bcl-3
and p52 were precipitated from the nucleus of RML6-
infected cells. For further evaluation of these results the
blots were quantiﬁed by scanning densitometry. While the
p65 to p50 ratio reached a value of 0.72 in control cells it
decreases to 0.42 after infection. The reduction of the
transcriptional active NF-kB subunit p65 supports the for-
mation of inactive homodimers like p50-p50. These
results are in line with the lack of transcriptional activity in
RML6-treated cells, as p50 and p52 lack a transcription
activation domain.
PrPSc induces apoptosis via mitochondrial disruption in
Bos-2 cells
It is well known that PrPSc induces apoptosis in neurons in
vitro and in vivo (Hetz and Soto, 2003; Cronier et al.,
2004). Nevertheless, the mechanism of cell death is not
Fig. 1. No transcriptional NF-kB activity after
PrP
Sc infection.
A. Electromobility shift assay revealed NF-kB
binding activity in PrP
Sc-infected
neuroblastoma cells (Bos2). Nuclear extracts
of Bos2 cells infected with RML6, treated with
CD1 or stimulated with 10 ng ml
-1 TNF-a were
incubated with
32P-labelled double-stranded
oligonucleotide speciﬁc for NF-kB. The TNF-a
sample was incubated with a 50-fold excess
of cold NF-kB oligonucleotide as speciﬁc
competitor or with a mutated oligonucleotide
as control.
B. kB precipitation experiment and detection
using antibodies directed against p65, p50,
p52 and Bcl-3. kB binding proteins were
precipitated from nuclear extracts using an
agarose-conjugated consensus kB
oligonucleotide. The precipitates from either
untreated controls, TNF-treated or
RML6-infected Bos2 cells were divided and
analysed in Western blots for the presence of
the various NF-kB subunits. The immunoblot
was quantiﬁed by scanning densitometry. The
total signal intensities (p65 + p50,
+p52 + Bcl-3) for the treated cells relative to
the control cells and the portion of each
subunits are given in percentage.
C. Luciferase reporter gene assay showed no
transcriptional NF-kB activity after PrP
Sc
infection (0.2% or 0.02%), the value of
relative light unit (RLU) per mg protein being
equivalent for RML6- and CD1-treated cells.
Mean values and SEM of three independent
transfections are shown.
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well described event in many cases of apoptosis and has
been reported to play a central role in neuropathological
processes (Polster and Fiskum, 2004). This pathway is
characterized by loss of transmembrane potential (Ym).
Analysis of Ym using the lipophilic ﬂuorescent dye JC-1
showed an increased number of cells with depolarized
Ym in RML6-treated cells (23.5%) compared with CD1-
treated control cells (5.7%), 18 h after RML6 infection
(Fig. 2A).
The release of cytochrome c from the mitochondrial
intermembrane space into the cytosol commonly follows
membrane depolarization. In order to determine the local-
ization of cytochrome c, mitochondrial and cytosolic frac-
tions of cells 18 h after incubation with RML6 or normal
brain homogenates were prepared. Staurosporine-treated
cells were used as positive control and the NF-kB inhibitor
BAY117082 was tested for its ability to induce cytochrome
c release. Using Western blot analysis cytosolic
cytochrome c was detected in staurosporine-,
BAY117082- and RML6- but not CD1-treated cells
(Fig. 2B). Consequently, our data show that infection of
Bos2 cells with RML6 leads to an early induction of a
decrease in the mitochondrial membrane potential, fol-
lowed by cytochrome c release into the cytosol.
The mitochondrial permeabilization and the release of
death-promoting factors into the cytosol depend on the
regulation by proteins of the Bcl-2 family (Kroemer, 1997).
To further investigate the apoptotic pathway a cDNA
microarray analysis was performed. Bos2 cells were
inoculated with RML6 and RNAwas extracted at 8, 18 and
30 h after treatment. CD1-treated Bos2 cells were used
as controls. To assure biological relevance three indepen-
dent experiments were performed, where the RNA from
cells was extracted. The PIQOR™ Cell Death Microarray
(Memorec) was used composed of genes encoding key
proteins in apoptosis, stress-like caspases, TNF-receptor
family members, Bcl-2 family members and heat shock
proteins. Various genes showed different expression pat-
terns at 8, 18 and 30 h after treatment and most of them
were signiﬁcantly regulated only at 18 h. At this time point
21 transcripts were differentially regulated. Their level of
regulation in RML6-treated cells compared with control
cells is summarized in Table 1. Interestingly among the 13
downregulated genes, ﬁve (Tnfrsf11a/Rank, CcnD1, Myc,
Junb and BclxL) are known to be NF-kB targets (Pahl,
1999). As Bcl-xL is involved in the regulation of mitochon-
drial apoptosis, the differential expression of Bcl-xL was
further conﬁrmed using real time quantitative PCR
(qPCR). Here, a 28% downregulation of Bcl-xL-speciﬁc
Fig. 2. PrP
Sc-induced mitochondrial disruption
leads to apoptosis.
A. JC-1 staining of staurosporine, CD1
(control) and RML6 cells. Cells treated with
staurosporine (1 mM, 4 h), CD1 or RML6 for
18 h were stained with JC-1 according to the
protocol and analysed on a BD FACS
Calibur™ as described in Experimental
procedures. JC-1 ﬂuorescence is seen in both
the FL-2 (red) and FL-1 channels (green).
JC-1 that ﬂuoresces in the FL-1 channel and
lacks ﬂuorescence in the FL2 channel is
considered to correspond to mitochondria with
a depolarized DY. For staurosporine-treated
cells 67% showed decreased ﬂuorescence in
the FL-2, while only a small proportion of the
population in CD1 control cells (5.7%) showed
depolarization of the DY. After RML treatment
23.5% of the cells mitochondria were found
with a depolarized DY.
B. Western blot analysis of mitochondrial
(mito) and cytosol fraction of untreated and
either staurosporine-, BAY117082-, CD1- or
RML6-stimulated Bos2 cells, using an
antibody directed against cytochrome c. Equal
loading was controlled by detection of ERK1/2
in the cytosol fraction.
C. Real time qPCR to detect murine bcl-xl
from RML6- versus CD1-treated cells. The
expression of bcl-xl normalized to 18S RNA
and the SEM for triplicate experiments are
given in percentage of the control (CD1).
Statistic analysis using the Mann–Whitney
rank sum test showed signiﬁcant differences
between RML6- and CD1-treated cells
(P = 0.028).
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was observed (Fig. 2C). This ﬁnding that Bcl-xL-speciﬁc
mRNA is downregulated in Bos2 cells after acute PrPSc
infection perfectly correlates with the mitochondrial dys-
function and the cytochrome c release.
Taken together, our data show that RML6 induces mito-
chondrial permeabilization and a decrease in mitochon-
drial membrane potential in Bos2 cells. Moreover, RML6
leads to downregulation of individual NF-kB target genes,
among them the anti-apoptotic regulator Bcl-xL.
PrPSc activates caspase-9 and caspase-3 in Bos-2 cells
Release of cytochrome c leads to speciﬁc activation of
caspase-9. Therefore, we investigated the expression of
this caspase in Bos2 cells. No caspase-9 activation was
found in untreated Bos2 cells or in CD1-treated cells,
whereas caspase-9 activation was found in persistently
infected N2A cells (ScN2A) (Fig. 3A). Positive cells for
active caspase-9 were also found after RML6 infection of
Bos2 cells and after treatment of these cells with either
BAY117082 or staurosporine. Moreover, these caspase-
9-positive cells showed chromatin condensation (yellow
arrows), which is a characteristic of cells undergoing
apoptosis. To further support these ﬁndings a quantitative
analysis of the ﬂuorescence staining was performed as
described in the ﬁgure legend. A 6.6-fold increase of
active caspase-9-positive cells was found after RML6
infection of Bos2 cells and a 11.4-fold increase in persis-
tently prion-infected N2A cells compared with Bos2 cells
(Fig. 3B). In contrast to N2A/Bos2 cells, GT1 cells were
not suitable for these experiments because of a high
caspase-9 activity in untreated cells (Fig. S1).
To further investigate the apoptotic events after acute
infection of Bos2 cells with RML6, ﬂuorescence staining
was also performed for the detection of activated
caspase-3. While no caspase-3 activity was found in unin-
fected Bos2 cells, activated protein was detectable in
RML6-infected Bos2 cells and in Bos2 cells treated with
the NF-kB inhibitor BAY117082 as a positive control. The
caspase-3-positive cells presented membrane blebbing
(red arrows), a hallmark of apoptosis (Glasgow and
Perez-Polo, 2000).
PrPSc infection of mice lacking NF-kB1,
NF-kB2 and Bcl-3
To investigate whether NF-kB is involved in prion patho-
genesis in vivo, we used mice lacking either p65 or p50,
compounds of the classical NF-kB pathway, or mice
lacking p52 or Bcl-3 for infection with PrPSc. In order to use
p65ﬂox/ﬂox/nestinCre/wt, Nfkb1–/–, Nfkb2–/– and Bcl3–/ mice for
our study, we ﬁrst investigated if all strains showed com-
parable expression of cellular PrP in the brain. Western
blot analysis indeed revealed comparable levels of PrPc in
all mouse strains tested (Fig. 5, data not shown).
Wild-type C57Bl/6 mice infected with RML6 developed
disease around day 136 post infection (p.i.) and became
terminal sick by day 158  10.1. Mice lacking NF-kB2
alreadydevelopeddiseasebyday120andwereterminally
Table 1. Differential gene expression in Bos2 + RML6 versus Bos2 + CD1 18 h p.i.
Name Gene ID SWISSPROT Function Fold/deviation
Upregulated
Lyar 22757 Q08288 Regulation of cell growth 1.82/11%
Chmp5 17765 Q9D7S9 Protein transport 1.82/11%
Fas 78 Q9DCQ1 Receptor for TNFSF6/FASLG 1.82/8%
MKi67 1222 Q61769 Antigen 2.06/18%
Hsp90aa1 1719 P07901 Heat shock protein 1.74/3%
Hsp105 3581 Q61699 Heat shock protein 1.79/13%
Trp53bp2 8225 Q8K2L5 Regulation of cell growth and apoptosis 1.74/13%
IFi203 18178 O353668 Interferon (IFN)-a-inducible protein 1.82/–%
Downregulated
Cdkn1B 90 P46414 Cell cycle regulation 0.53/13%
CcnD1
a 123 P25322 Cell cycle regulation 0.50/7%
Ngfr 235 Q9Z0W1 Regulation of cell survival as well as cell death of neural cells 0.46/3%
Tnfrsf11a
a 244 Q8VCT7 Receptor for TNFSF11/RANKL 0.35/18%
Bcl2l13 269 P59017 Apoptose regulator 0.52/13%
Junb
a 3865 Q8C2G9 Transcription factor 0.56/13%
Tyk2 4106 Q8VE41 Signal transduction of type I and type II IFN 0.58/0%
Myc
a 4192 P01108 Regulation of gene transcription 0.58/6%
Tcfe3 4260 Q8K420 Transcription factor 0.46/6%
Enc1 8555 O35709 Actin binding protein 0.26/5%
Bcl-X
a 64 Q64373 Apoptosis inhibitor 0.58/13%
Tollip 18989 Q9QZ06 IL-1 and Toll-like receptors signalling 0.53/9%
Ticam1 21115 Q8JZV0 Toll-like receptors signalling 0.56/8%
a. Indicates NF-kB target genes.
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disease symptoms around day 128 p.i. and terminal
disease by day 143  5.8 after infection. This demon-
stratedasigniﬁcantincreaseinonsetofterminaldiseasein
Bcl-3-deﬁcient (P = 0.0001) and NF-kB2-deﬁcient
(P = 0.01)mice.AstheNfkb1–/–miceshowedanunspeciﬁc
background, Nfkb1 heterozygous littermates were used as
controls. These animals developed disease after RML6
infection at time points comparable to C57Bl/6 mice (onset
143, terminally sick 158  11.9). When Nfkb1–/– mice were
inoculatedwithRML6theyshowedﬁrstsignsofdiseaseby
day 143 p.i. and the end stage of disease at
153  5.6 days after infection.Thus, there is no signiﬁcant
difference (P = 0.18) of incubation time in mice lacking
Fig. 3. PrP
Sc induced the activation of
caspase-9 and caspase-3.
A. Detection of active caspase-9 and
caspase-3 in untreated Bos2 and ScN2a cells
and in Bos2 cells treated with CD1, RML6,
BAY117082 or staurosporine for 20 h. The
active caspase staining is shown in green and
the nuclear DAPI staining is shown in blue.
Cells presenting chromatin condensation are
indicated with yellow arrows and blebs with
red arrows.
B. Quantitative analysis of active caspase-9 in
Bos2, RML6-infected Bos2 and ScN2A cells.
Cleaved caspase-9-positive cells were given
in percentage of control (untreated Bos2
cells). The cells from one of three
representative experiments per 50 mm
2 were
counted.
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furtherelucidatetheroleoftheclassicalNF-kBpathwaywe
infected p65-deﬁcient mice. Tissue-speciﬁc p65-deﬁcient
mice were generated by crossing p65ﬂox/ﬂox mice with CNS-
speciﬁc nestin-Cre mice. p65ﬂox/ﬂox/Cre-negative animals
have a normal p65 expression in the brain and developed
disease after RML6 infection at time points comparable to
C57Bl/6 mice (onset 141, terminal stage of disease
157  8.3, P = 0.62). The Cre-positive mice (p65ﬂox/ﬂox/
nestinCre/wt) with p65 deletion in the CNS showed no differ-
ence to their control littermates (onset 141, terminal stage
of disease 156  11.0, P = 0.28).
Spongiform encephalopathy and expression of Bcl-xL,
active caspase-9 and active caspase-3 in
NF-kB-deﬁcient mice after PrPSc infection
In experimental prion disease of mice, the quantity of
PrPSc in the brain and the neuropathological changes after
infection characterized by spongiform encephalopathy
can not always be correlated with clinical symptoms or
onset of disease (Hill et al., 2000). In C57Bl/6 mice PrPSc
deposition and spongiosis was predominantly found in the
cerebellum, pons, entorhinal cortex, medulla and to lower
extends in the thalamus. In Bcl-3- and NF-kB2-deﬁcient
mice the amount and the distribution of PrPSc was com-
parable to the C57Bl/6 wild-type control mice as demon-
strated by immunohistochemistry (data not shown) and
Western blot analysis (Fig. 5A). Analysis of control and
NF-kB-deﬁcient animals at the exact same day post infec-
tion (112 p.i.) revealed comparable amount of PrPSc too,
albeit variation of the signal after protease K digestion
between the individual animals was observed in all panels
(Fig. 5B). More interestingly, the level of vacuolation in the
terminal stage of disease was also comparable to the
wild-type animals, even though the onset of disease in
NF-kB2- and Bcl-3-deﬁcient mice was earlier (Fig. 6A).
Fig. 4. Terminal disease in NF-kB-deﬁcient
mice after PrP
Sc infection.
A. Kaplan Meier survival curves of wild-type,
NF-kB2- and Bcl-3-deﬁcient mice. Bcl3
–/–,
Nfkb2
–/– and C57Bl/6 mice as control were
inoculated intracerebrally with 30 ml of 0.2%
(w/v) RML6 brain homogenate, monitored
daily for clinical symptoms and euthanized at
the end-point of neurological disease.
B. Mean of survival and SEM for all mice
lines analysed are represented. Terminal
disease stage is signiﬁcantly reduced in
NF-kB2-deﬁcient (P = 0.01) and
Bcl-3-deﬁcient (P = 0.0001) mice compared
with C57Bl/6 mice. NF-kB1-deﬁcient mice
showed no difference in the time-course of
the disease compared with relevant
heterozygous controls (P = 0.18). See
Experimental procedures for detailed
description of mice stains. Mice with p65
deletion in nestin expressing cells
(p65
ﬂox/ﬂox/Nestin
Cre/wt) showed no difference in
disease development compared with mice
with intact p65 expression (p65
ﬂox/ﬂox)
(P = 0.285). Number of mice (n) and P-value
are given.
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amounts of PrP.
A. Western blot analysis of brains
homogenates subjected to electrophoresis in
native form (–) or after digestion with
proteinase K (+) showed nearly similar
amounts of PK-resistant PrP
Sc in knockout
and wild-type mice that had developed
terminal disease.
B. Analysis of brains homogenates at
112 days p.i. revealed comparable amounts of
prion protein. Variation between individual
animals for PK-resistant PrP
Sc was observed
in wild-type and NF-kB-deﬁcient mice. C
indicated a control performed with
non-infected brain homogenate of C57Bl/6
mice, where no prion protein can be detected
after PK treatment.
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Fig. 6. Lesions in the brain and p65 detection
of PrP
Sc-infected mice.
A. Terminally sick mice showed comparable
vacuolation (haematoxylin/eosin staining,
H&E) after i.c. inoculation of PrP
Sc. The pons
areas of midsagittal sections are shown.
Magniﬁcation ¥20. Three mice of each strain
were analysed.
B. Strong reduction of activated NF-kB
(phospho-p65) in PrP
Sc-infected C57Bl/6 mice.
Uninfected and infected animals at 11 weeks
p.i. were sacriﬁced and the brain of three
animals per group were analysed by
immunohistological staining using a
phospho-p65-speciﬁc antibody.
Representative pons areas of midsagittal
sections are shown. Magniﬁcation ¥10.
A C57Bl/6 Nfkb2
-/- Bcl3
-/-
Nfkb1
-/- p65flox/flox
B Uninfected PrPScinfected (11 weeks p.i.)
p65flox/flox/nestinCre/wt
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1995). According to our in vitro data (Fig. 1), we now
raised the question, whether the level of active p65 is
altered in the CNS of mice after PrPSc infection. While in
uninfected C57Bl/6 mice the presence of active p65 is
clearly demonstrated, a reduction of active p65 was found
in mice 11 weeks after PrPSc infection (Fig. 6B).
Our in vitro experiments demonstrated that prion infec-
tion resulted in mitochondria-mediated apoptosis associ-
ated with reduction of Bcl-xL speciﬁc mRNA expression,
cytochrome c release and activation of caspase-9 and
caspase-3. We now questioned if this mechanism of cell
death might be also functional in the in vivo situation. Mice
were infected intra-cerebral (i.c.) with RML6 and the
brains of these animals were investigated by immunohis-
tochemistry at various time points after infection until the
terminal disease stage. At late stages of the disease,
when neurodegeneration becomes obvious, no differ-
ences in the expression of Bcl-xL in C57Bl/6 mice com-
pared with Nfkb1–/–, Nfkb2–/– and Bcl3–/– mice were found
(data not shown). An increase of Bcl-xL-positive cells in
RML6-infected C57Bl/6 mice compared with uninfected
animals was found at 11 weeks after infection, while a
reduced number of Bcl-xL-expressing cells was found in
the brain of NF-kB2- and Bcl-3-deﬁcient mice compared
with C57Bl/6 mice at the same time point (Fig. 7A). Inter-
estingly, in NF-kB1-deﬁcient mice Bcl-xL staining was
comparable to C57Bl/6 mice. These observations were
supported by quantitative analysis of the brain section
(Fig. 7B). Roughly, a 60% reduction of Bcl-xL-positive cells
was found in the brain of NF-kB2- and Bcl-3-deﬁcient
mice compared with C57Bl/6 mice.
Activation of caspase-9 is involved in the major mito-
chondrial apoptotic pathway. By immunohistochemistry
activation of caspase-9 was found in the brain of prion-
infected mice but only slight differences between the
various mouse strains concerning the number of positive
cells were present (Fig. 7A). This was most probably due
to high caspase-9 expression in uninfected mouse brains.
Therefore, in addition, immunohistological analysis of
activated caspase-3 was performed. Activation of
caspase-3 by cleavage of the pro-caspase-3 is a central
step to induce apoptosis. Detection of active caspase-3 is
a solid and useful marker to investigate apoptosis. By
immunohistochemistry, even in a normal adult mouse
brain active caspase-3-positive cells can be found in par-
ticular in the olfactory bulb and single positive cells can be
detected throughout the brain. The picture of active
caspase-3-positive cells totally changes in PrPSc-infected
mice at terminal disease stage. Here, intensive active
caspase-3 staining can be found basically in all areas
where spongiform vacuolation is found, and to lower
extends also in areas of the brain without obvious neuro-
pathological changes. When brains of either terminally
diseased wild-type or NF-kB-deﬁcient mice were analy-
sed in immunohistochemistry with an antibody directed
against active caspase-3, no differences in the amount
and the distribution of active caspase-3 was found (data
not shown). Therefore, we investigated brain sections at
earlier time points after PrPSc infection. According to the
results of Bcl-xL expression, brain sections were tested for
caspase-3 activity at 11 weeks p.i. Here, we found
increased caspase-3 activity in NF-kB2- and Bcl-3-
deﬁcient mice compared with C57Bl/6 and NF-kB1-
deﬁcient mice (Fig. 7A). Quantitative analysis of caspase-
3-positive cells revealed a 65% increase in Bcl-3-deﬁcient
mice and an 82% increase in NF-kB2-deﬁcient mice
(Fig. 7C). The reduction of the anti-apoptotic protein
Bcl-xL correlates with the increased activation of
caspase-9 and more obvious to an increased activation of
caspase-3 that consequently leads to apoptosis.
Discussion
A notable feature in prion disease is a progressive loss of
neurons, gliosis and spongiform changes. The cellular
mechanisms of nerve cell death is still poorly understood,
but it has been shown that apoptosis plays a major role
(Giese et al., 1995; Lucassen et al., 1995; Hetz et al.,
2003). Our data suggest that NF-kB is involved in early
events leading to apoptosis and show that apoptosis
might not be the only factor involved in the pathology of
the disease.
How can NF-kB’s mode of action be envisioned? Acti-
vation of the transcription factor kB in the central nervous
system prevents neuronal apoptosis in cell culture and in
animal models (Barger et al., 1995; Kaltschmidt et al.,
1995; Mattson et al., 1997). Several studies have shown
that neuronal dysfunction after prion infection occurs
through a process of programmed cell death. This is true
in the murine experimental models for scrapie but also for
Creutzfeldt-Jakob Disease (CJD) in humans (reviewed in
Hetz and Soto, 2003). Apoptosis was also found in
primary cultured neurons, in a hypothalamic neuronal cell
line and in neuroblastoma cells (Barger et al., 1995; Hetz
et al., 2003; Cronier et al., 2004; Kristiansen et al., 2005).
Our experiments demonstrated that after acute prion
infection of Bos2 neuroblastoma cells with PrPSc (RML6),
NF-kB binding activity was detectable but no transcrip-
tional activity. This obvious discrepancy could be solved
when the subunits of the NF-kB complex were identiﬁed to
demonstrate that p65 did not translocate to the nucleus of
RML6-infected Bos2 cells. Furthermore, in vivo a reduced
expression of phospho-p65 was found in PrPSc-infected
C57Bl/6 mice at early stages of the disease (11 weeks)
compared with uninfected mice. In contrast to p65, the
NF-kB proteins p50 and p52 lack a transactivation domain
and cannot achieve for the activation of transcription.
2210 S. Bourteele et al.
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Cellular Microbiology, 9, 2202–22170
20
40
60
80
100
120
140
160
180
200
220
0
20
40
60
80
100
120
A
C B
C57Bl/6 Nfkb1
-/- Bcl3
-/- Nfkb2
-/-
B
c
l
-
x
L
c
l
.
 
c
a
s
p
a
s
e
-
3
c
l
.
 
c
a
s
p
a
s
e
-
9
%
 
o
f
 
c
o
n
t
r
o
l
C
5
7
B
l
/
6
N
f
k
b
1
-
/
-
B
c
l
3
-
/
-
N
f
k
b
2
-
/
-
Bcl-xL
C
5
7
B
l
/
6
N
f
k
b
1
-
/
-
B
c
l
3
-
/
-
N
f
k
b
2
-
/
-
cl. caspase-3
Fig. 7. Reduced Bcl-xL expression correlates with enhanced caspase-3 activation in NF-kB2- and Bcl-3-deﬁcient mice after 11 weeks of PrP
Sc
infection.
A. Bcl-xL expression (black arrows), active cleaved caspase-9 and caspase-3 were determined by immunohistological staining. Bcl3
–/–,
Nfkb2
–/–, Nfkb1
–/– and C57Bl/6 mice were inoculated with RML6 and three animals per groups were sacriﬁced at 11 weeks p.i. Brain sections
of three animals were analysed for each mouse line. Representative areas of the entorhinal cortex are shown. Magniﬁcation ¥20.
B and C. For quantiﬁcation of positive cells, three sections of three different mouse brains for each strain were chosen. The graphic
represents the amount of positive cells in the brain of the deﬁcient mice compared with the C57Bl/6 mice in percentage of control. SEM was
shown as bars. For detailed information on quantiﬁcation see Experimental procedures.
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ciated with repression of transcription (Bours et al., 1993;
Kastenbauer and Ziegler-Heitbrock, 1999). In fact, we
observed a downregulation of NF-kB target genes like
RANK, cyclinD1 and Bcl-xL in acute PrPSc-infected cells
(Pahl, 1999; Shishodia et al., 2005). This is in agreement
with results obtained from persistently infected ScN2A
cells, where various genes involved in translation or
protein synthesis were downregulated (Greenwood et al.,
2005). Our data on NF-kB DNAbinding activity after PrPSc
infection are supported by the work of Fabrizi et al. (2001)
which described NF-kB activity in human microglial cells
after stimulation with the prion protein fragment 106–126.
Furthermore, NF-kB activity has been found in brains of
scrapie-infected mice at the terminal state of the disease
(Kim et al., 1999).
One might now raise the question whether the repres-
sion of NF-kB activity participates to neuronal cell death
after PrPSc infection. Our data support the view that PrPSc
leads to mitochondrial dysfunction, cytochrome c release,
activation of caspase-9 and caspase-3 and subsequently
to apoptosis. In neuropathological processes mitochon-
drial dysfunction is often present, and it is well known that
mitochondria are involved in neuronal cell apoptosis
(Polster and Fiskum, 2004). Cytochrome c released from
mitochondria together with other proteins leads to the
production of active caspase-9 that again induces
caspase-3 activation and results in apoptosis (Shi, 2002).
Furthermore, our data support earlier ﬁndings where the
synthetic peptide PrP (106–126) of prion protein was able
to induce cell death by mitochondrial disruption in
neuronal cells (O’Donovan et al., 2001).
In the last decade, members of the Bcl-2 protein family
have emerged as important regulators of the mitochon-
drial membrane potential (Ym). Their exact mechanism is
yet not completely understood but it is a general hypoth-
esis that anti-apoptotic Bcl-2 inhibits the opening of pores
at the mitochondrial outer membrane and thereby pre-
vents the loss of Ym, which consequently prevents the
release of cytochrome c and apoptosis (Kroemer, 1997).
In our microarray analysis we found downregulation of
Bcl-xL after acute infection of Bos2 cells. The death
antagonist Bcl-xL is a member of the Bcl-2 protein family.
Interestingly, BclxL was reported to be an NF-kB target
gene (Pahl, 1999). Other inhibitors of apoptosis proteins
(IAP, XIAP, NAIP) or FLIP block the activation of
caspases, particularly those involved in engagement of
the receptor-related, extrinsic apoptotic pathway (Karin
and Lin, 2002). In our microarray analysis we found no
differences in the regulation of IAPs. One therefore might
argue that apoptosis after acute PrPSc infection is pre-
dominately regulated by the intrinsic, mitochondrial apo-
ptotic pathway. Using N2A cells stably expressing mutant
form of Bcl-2, it has been described that Bcl-2 regulates
the induction of apoptosis mediated by endoplastic reticu-
lum (ER) stress rather than by mitochondrial dysfunction
after PrPSc infection (Hetz et al., 2003). We cannot rule out
that Bcl-xL exerts another function than Bcl-2 and it could
be possible that in addition to the mitochondial dysfunc-
tion, PrPSc induced cell death over ER stress and
caspase-12 activation. Nevertheless, in permanently
PrPSc-infected hypothalamic neurons (Sc-GT1 cells) an
apoptotic pathway involving formation of aggresomes
together with the activation of caspase-8 and caspase-3
was described (Kristiansen et al., 2005). While these cells
contain high levels of prion protein, this cell culture model
may rather reﬂect the situation at the late stage of the
disease, whereas the NF-kB repression and the involve-
ment of mitochondria leading to neuronal apoptosis within
24 h in acute infected Bos2 (N2A) cells may represent an
early event after PrPSc infection.
Consequently the question now arises, if our ﬁndings
based on cell culture experiments also reﬂect the situation
in vivo. To analyse various NF-kB signalling pathways we
used NF-kB1-, NF-kB2- and Bcl-3-deﬁcient mice and
animals with p65 depletion in the CNS for infection with
PrPSc. Except the p65–/– line, these deﬁcient mice have
severe defects in their lymphoid organs (reviewed in
BonizziandKarin,2004),whichareimportantsitesofprion
replication upon intra-peretonial (i.p.) prion inoculation.As
we exclusively performed i.c. inoculation these mouse
strains were adequate for our studies. Interestingly, the
enhanced susceptibility of NF-kB2- and Bcl-3-deﬁcient
animals compared with NF-kB1-deﬁcient mice and wild-
type controls correlates with a reduced expression of the
anti-apoptotic protein Bcl-xL 11 weeks after prion infection.
This is in line with our in vitro results, where Bcl-xL mRNA
was downregulated in acute PrPSc-infected cells. Further-
more, enhanced cleaved caspase-3 activity was found in
NF-kB2- and Bcl-3-deﬁcient mice at the same time point.
The different patterns of caspase-3 expression and the
reduced level of Bcl-xL in the NF-kB2- and Bcl-3-deﬁcient
animals argue for a Bcl-xL-dependent protection in the
wild-type mice at early stages of the disease. This is in line
with the previously reported neuroprotective role of NF-kB
(Glasgow and Perez-Polo, 2000; Dhantapani et al., 2005).
The involvement of the mitochondrial apoptotic pathway in
mice suffering from prion disease is under debate. Bax-
deﬁcient mice inoculated with a mouse-adapted BSE
strain, presented the same pathology compared with
control animals (Coulpier et al., 2006). Recently, both Bax-
dependent and Bax-independent neurotoxic pathways
were found in mice with N-terminally deleted forms of the
prion protein (Li et al., 2007).
Taken together, our data provide new insides into the
mechanism of neuronal cell death early after prion
infection. By a so far unknown reason the NF-kB subunit
p65 is reduced in early stages after PrPSc infection. The
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may bind to the promoter region, leading to downregula-
tion of genes coding for anti-apoptotic proteins like Bcl-xL.
From previous studies it is known that Bcl-3 can function
as coactivator for p50 and p52 homodimers (Bours et al.,
1993; Bonizzi and Karin, 2004). Nevertheless, the role of
Bcl-3 in the CNS is almost completely unidentiﬁed. A
strong signal for Bcl-3 was found in the nucleus of PrPSc-
infected Bos2 cells. Therefore, one might speculate that
Bcl-3 reverses the repression and induces gene
expression. This hypothesis is supported by the earlier
onset and terminal stages of disease in mice with either
disrupted Bcl-3 or Nfkb2 genes. As prion infection of wild-
type mice and NF-kB-deﬁcient mice equally resulted in
death, one is tempted to argue about the contribution of
NF-kB and apoptosis in prion disease. From our and from
other studies it is clear that NF-kB activity is not the only
factor leading to disease. At a late time point of the
disease microglia and astrocytes are activated and
produce chemokines and cytokines, which have been
associated with the death of the surrounding neurons
(Mallucci et al., 2003; Bate et al., 2004). These chemok-
ines and cytokines probably induce apoptosis via a direct
pathway independent of mitochondria and Bcl-xL
expression. This is in line with our ﬁnding of strong
caspase-3 activation in all animals in the terminal stage of
the disease. In addition, a neuroprotective mechanism
against prion neurotoxicity was described, involving the
early expression of the ER chaperones Grp58, which
counterparted cell death after stress (Hetz et al., 2005).
Nevertheless, the ﬁndings that in early stages of the
developing disease mitochondrial defence mechanisms
are involved in neuroprotective processes brings impor-
tant aspects to the understanding of the development of
prion disease. Interestingly, Bcl-xL and other anti-
apoptotic proteins were induced by estrogen, a hormone
that can protect neurons against neurodegenerative pro-
cesses and which therapeutic application is considered
for prevention or treatment of neurodegenerative disor-
ders like Alzheimer’s disease (reviewed in Nilsen and
Brinton, 2004). Targeting mitochondrial function would be
an approach to achieve neuron viability and reﬂects new
defence strategies against neurodegenerative diseases.
Experimental procedures
Mice
NF-kB1-deﬁcient mice with an unspeciﬁed background (129-
derived E14 ES cell line was used) were purchased from the
Jackson Laboratory. All mice were bred and housed in a conven-
tional animal facility at the Friedrich-Loeffler-Institut. Because of
the unspeciﬁed background Nfkb1–/– mice were crossed with
C57Bl/6 mice. The heterozygous offsprings were crossed with
Nfkb1
–/– mice resulting in 50% Nfkb1
–/– mice and 50% Nfkb1
+/–
mice. The Nfkb1
+/– littermates functioned as controls. Generation
of Bcl3
–/– and Nfkb2
–/– mice was reported elsewhere. In brief,
exons 3–5 and a part of exon 6 from the Bcl3 gene were replaced
by a neomycin cassette (Riemann et al., 2005). In NF-kB2-
deﬁcient mice exons 1b-9 were replaced (Paxian et al., 2002).
Bcl3
–/– and Nfkb2–/– mice were backcrossed into C57Bl/6 strain at
least 10 times. As the p65 knockout is lethal, tissue-speciﬁc
animals were generated. The Cre–loxP recombination system
was used to excise exons 7–10, coding for a part of the Rel
homology domain and the nuclear localization sequence (NLS) of
the p65 gene. The nestin-cre mice are published (Betz et al.,
1996) and p65
ﬂox/ﬂox mice will be described elsewhere (R.M.
Schmid, manuscript in preparation). Intercrossing of the p65
ﬂox/ﬂox
mouse line with mice carrying nestin
Cre/wt leads to a p65
ﬂox/ﬂox/
nestinCre/wt mouse line with a CNS-speciﬁc deletion of p65 and
p65
ﬂox/ﬂox control littermates. All mice were healthy, fertile and
born at the expected mendelian ration. Conditional deletion of
p65 in neuronal cells was conﬁrmed by Southern blot analysis
and is shown elsewhere (Inta et al., 2006).
Cell lines
The mice cell line N2A was subcloned and cells highly suscep-
tible for PrP
Sc were described as Bos2 cells and used as a
standard laboratory cell line for infection (Bosque and Prusiner,
2000). Permanently PrP
Sc-infected N2A cells (ScN2A) were
kindly provided by Dr Aguzzi (Zürich) and Dr Korth (Düsseldorf).
Presence of PrP
Sc was controlled on a regular basis using cell
blot technique. Cells were cultured in Iscove’s modiﬁed Eagle’s
medium supplemented with 10% fetal calf serum, 2 mM
L-glutamine and 100 U ml
-1 gentamicin. Cells were maintained at
3 7 ° Ci n5 %C O 2.
Prion inoculations
RML6 scrapie strain was used throughout these experiments and
was produced in the Friedrich-Loeffler-Institut in collaboration
with Dr Aguzzi, Zürich. The inocula were prepared from brain
tissue homogenized in steril 0.32 M sucrose at 20% (w/v). The
mice were inoculated intracerebrally with 30 ml of 0.2% (w/v)
RML6 brain homogenate or normal brain homogenate from CD1
control mice. Inoculated animals were monitored daily for clinical
symptoms and euthanized at the end-point of neurological
disease and dysfunction if not otherwise mentioned. For infection
of Bos2 cells 20% RML6 or CD1 brain homogenate was added to
the culture media at a 1/100 (0.2%) or a 1/1000 (0.02%) ratio
(v/v). Cells were tested for the presence of PrP
Sc using the cell
blot technique according to Bosque and Prusiner. In brief
1.5 ¥ 10
5 Bos2 cells were seeded in two wells of a 6-well culture
plate and infected at the next day. After 24 h in the presence of
the inoculum the cells were splitted at a 1:5 ratio in normal
medium. Cell blotting was performed at 7 days post inoculation
after three times splitting in new plates to remove the initial brain
inoculum. By the last passage 1 ¥ 10
4 Bos2 cells were seeded on
glass coverslips and were transferred to the nitrocellulose
membrane. To detect PrP
Sc cell blot membrane was treated with
5 mgm l
-1 proteinase K prior to prion detection.
EMSA
For preparation of nuclear extracts, 2 ¥ 10
5 Bos2 cells were
seeded in 60 mm cell culture dishes and were infected at the
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recombinant human TNF-a for 40 min (ImmunoTools). Cells
were washed twice with cold PBS and harvested in 400 mlo f
buffer A (10 mM KCl; 10 mM HEPES, pH 7.9; 0.1 mM EDTA;
0.1 mM EGTA; 1 mM DTT and 1 mM PMSF). After 5 min at 4°C,
the cells were passed 10 times through syringe needles (26
gauge). The nuclei were pellet and resuspended in 50 mlo f
buffer B (20 mM HEPES, pH 7.9; 0.4 M NaCl; 1 mM EDTA;
1 mM EGTA and 1 mM DTT). After 20 min of shaking and sub-
sequent centrifugation, the protein concentration of nuclear
extracts was determined (Bio-Rad). Eight micrograms of nuclear
extract were incubated with 4 mg of poly(dI-dC)
2 in binding buffer
(0.1 M KCl; 10 mM Tris/HCL, pH 7.5; 5 mM MgCl2; 1 mM DTT
and 10% glycerol). After 20 min, 2–5 ¥ 10
4 c.p.m. of
32P-labelled
oligonucleotides (5′-GATCCAGAGGGGACTTTCCGAGTAC-3′)
were added to the mixture and further incubated for 10 min at
room temperature. Alternatively, the NF-kB consensus oligo-
nucleotide (5′-AGTTGAGGGGACTTTCCCAGGC-3′) and the
mutant oligonucleotide (5′-AGTTGAGGCGACTTTCCCAGGC-
3′) as controls for speciﬁc competition with unlabelled DNA
probes were used. The samples were separated on a no dena-
turing 5% polyacrylamide gel. After drying the gel was subjected
to autoradiography.
Precipitation of NF-kB binding proteins
For precipitation of NF-kB binding proteins in nuclear extracts, an
agarose-conjugated consensus kB oligonucleotide (GGG-
GACTTTCCC) was used (Santa Cruz Biotechnology). Bos2 cells
(1 ¥ 10
6) were infected with RML6 (0.2%) or treated with
10 ng ml
-1 TNF-a for 40 min. After 18 h nuclear proteins from
control and stimulated Bos2 cells were isolated as described for
EMSA. Nuclear extracts from 1 ¥ 10
6 Bos2 cells were incubated
for 2 h at 4°C with 25 ml of beads in 400 mlo fkB buffer (20 mM
HEPES, pH 7.9; 50 mM NaCl; 0.5 mM EDTA and 1 mM DTT).
The precipitated proteins were washed three times and subjected
to analysis by SDS-PAGE and Western blot. The membranes
were blocked with 1% BSA and 1% non-fat milk in TBST (10 mM
Tris/HCl, pH 8.0; 150 mM NaCl and 0.05% Tween 20) for 1 h. For
detection antibody against p52 (sc-7386x), p50 (sc-114x) (Santa
Cruz Biotechnology), p65 (14-6731, ebioscience) were diluted
1/1000 and the anti-Bcl-3 antibody (sc-185) was diluted 1/200 in
blocking buffer.After incubation overnight at 4°C, the membranes
were washed three times with TBST and incubated with HRP-
conjugated goat anti-rabbit IgG (7074, Cell Signaling) or anti-
mouse IgG (sc-2005) for 1 h. Immune-reactive proteins were
visualized by enhanced chemoluminescence (ECL) detection
system (Santa Cruz Biotechnology).
Luciferase reportergene assay
Bos2 cells (5 ¥ 104) were plated in 24-well plates and were trans-
fected with 0.05 mgo f3 ¥k B reporter plasmid and 0.2 mlo fL i p o -
fectamin
TM 2000 (Invitrogen).After 6 h cells were either untreated
(control) or treated with TNF-a 10 ng ml-1, RML6 or CD1 (0.2% or
0.02%). Twenty-four hours after transfection, the luciferase activ-
ity of 20 ml of cleared lysate was quantiﬁed in a luminometer
(Lumat LB 9501) as described previously (Bourteele et al., 2005).
For normalization protein concentrations were determined by the
Bradford method (Bio-Rad).
Mitochondrial membrane potential
Bos2 cells in a concentration of 5 ¥ 105 in 5 ml of culture medium
were seeded in 60-mm cell culture dishes and inoculated at the
next day with RML6 or CD1 (0.2%) or treated with 1 mM stauro-
sporine (Sigma) for 18 h. For determination of mitochondrial
potential the cells were stained with JC-1 for 15 min at 37°C
according to the instruction of the manufacturer and analysed by
ﬂow cytometry (MitoScreen Kit, BD bioscience). When Bos2 cells
were incubated with JC-1, JC-1 penetrates the plasma mem-
brane of cells as monomers. Uptake of JC-1 into mitochondria is
driven by the DY. The DY of normal, healthy mitochondria is
polarized and JC-1 is rapidly taken up by such mitochondria. This
uptake increases the concentration gradient of JC-1 leading to
the formation of JC-1 aggregates within the mitochondria. JC-1
aggregates show a red spectral shift resulting in higher levels of
red ﬂuorescence emission which is measured in the Red (FL-2)
channel. JC-1 does not accumulate in mitochondria with depo-
larized DY and remains in the cytoplasm as monomers. These
monomers do not have the red spectral shift, and therefore have
lowered ﬂuorescence in the FL-2 channel.
Extraction of mitochondrial and cytoplasmic proteins
and cytochrome c detection
Bos2 cells in a concentration of 1 ¥ 106 in 10 ml of culture
medium were seeded in 100-mm cell culture dishes and inocu-
lated at the next day with RML6 or CD1 (0.2%) or treated with
1 mM staurosporine or 10 mM BAY117082 (Calbiochem) for 4 h.
Preparations of cytoplasmic and mitochondrial protein extracts
were performed and cytochrome c was visualized by Western
blot analysis as previously described (Liptay et al., 2002) using
an anti-cytochrome c antibody (BD Biosciences) at the ﬁnal con-
centration of 1 mgm l
-1.
Immunoﬂuorescence
Bos2 and ScN2A cells were cultured on glass coverslips in a
24-well plate and inoculated at the next day with RML6 or CD1
(0.2%) or treated with 1 mM staurosporine or 10 mM BAY117082
for 4 h. Cells were ﬁxed using 4% paraformaldehyde for 20 min at
room temperature, washed three times with PBS and permeabi-
lized in -20°C cold methanol on ice for 2 min. Non-speciﬁc immu-
nostaining was blocked by incubating the cells in 1% BSA, 10%
goat serum in TBS. Active caspases-9 and caspase-3 were
detected using antibodies directed against cleaved caspase-9
and cleaved caspase-3 (New England Biolabs) at 1/300 dilution
in 1% BSAin TBS and incubated overnight at 4°C.After washing,
cells were incubated for 1 h at room temperature with an FITC-
conjugated goat anti-rabbit IgG (Dianova) at a 1/3000 dilution in
1% BSA in TBS. After washing the cells were incubated with
0.2 mgm l
-1 4′,6′-diamino-2-phenylindole (DAPI; Sigma) for 5 min.
The cells were washed, mounted and analysed using anAxiovert
microscope and imaging system from Zeiss.
Western blot analysis of PrP
Brain tissue of PrP
Sc-infected mice was homogenized in 0.32 M
sucrose with a microhomogenizer. For analysis of PrP
Sc in termi-
nal sick mice, 1 mg of homogenate in 2% sarkosyl was treated
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treatment (20 mgm l
-1, 30 min, 37°C). Proteins were precipitated
using phosphotungic acid (0.28% in 11.8 mM MgCl2, 30 min,
37°C). Samples were centrifuged (30 min, 18 000 g) and the
pellets were resuspended in 20 ml of 0.1% sarkosyl. After disso-
lution 8 ml of loading buffer (Rotiload, Roth) was added and the
extracts were heated at 95°C for 5 min. A total of 250 mgo f
proteinase K-treated and -precipitated brain homogenate and
50 mg of precipitated but not digested homogenate were sub-
jected to SDS-12.5% polyacrylamide-gel electrophoresis. For
comparison at 112 days p.i., protein concentrations were deter-
mined by the Bradford method (Bio-Rad) and exact 50 mgo f
proteinase K-treated brain homogenate (20 mgm l
-1, 60 min,
37°C) and 50 mg of not digested homogenate were used. Pro-
teins were transferred to Immobilon P membrane (Millipore).
Membranes were blocked with Tris-buffered saline containing
0.1% Tween 20 and 5% non-fat milk, incubated with monoclonal
antibody POM1 (kindly provided by Dr Aguzzi, Zürich) and
detected by ECL (Santa Cruz Biotechnology).
Microarray analysis
Bos2 cells in a concentration of 1 ¥ 10
6 in 10 ml of culture
medium were seeded in 100-mm cell culture dishes and infected
at the next day with RML6 or CD1 (0.2%). RNA was extracted at
2, 8, 18 and 30 h after treatment, using Trizol reagent (Invitrogen)
according to manufacturer’s instructions. To assure biological
relevance pooled RNA was extracted from three independent
experiments and was used for analyses. The PIQOR™ Cell
Death Microarray (Memorec) was used that is composed of
genes encoding key proteins in apoptosis and stress-like
caspases, TNF-receptor family members, Bcl-2 family members
and heat shock proteins. The microarray was performed and
analysed by Memorec.
Real time qPCR
RNA samples derived from CD1-treated and PrPSc-infected Bos2
cells were used to synthesize single-stranded cDNAs. Reverse
transcription was carried out in a reaction volume of 20 ml con-
taining 1 mg of total RNA, 120 ng of random hexamer primer
(Amersham Biosciences), 0.5 mM dNTPs (Promega), 10 U
RNasin® (Promega), 10 mM DTT, 200 U SuperScript™ II
reverse transcriptase (Invitrogen), and the reaction buffer sup-
plied with the enzyme. Negative control reactions were carried
out for each sample by replacing the enzyme with water. The
mixture was incubated at 25°C for 10 min, 42°C for 50 min and
70°C for 15 min. Real time qPCR was performed using the ABI
PRISM® 7000 Sequence Detection System (Applied Biosys-
tems, Darmstadt, Germany). SYBR® Green PCR Master Mix
(Applied Biosystems) was used for PCR ampliﬁcation and real
time detection of PCR products. Primers (MWG Biotech) speciﬁc
for murine bcl-xl were designed to have a melting temperature of
60°C (forward primer: 5′-GTCAGCCAGAACCTTATCTTGG-3′,
reverse primer: 5′-GCTCAACCAGTCCATTGTCC-3′). 18S
RNA was chosen as a reference for normalizations (forward
primer: 5′-CGGCTACCACATCCAAGGAA-3′, reverse primer:
5′-GCTGGAATTACCGCGGCT-3′). PCRs were carried out in
20 ml with 300 nM of each primer and with the following tempera-
ture proﬁle: 50°C for 2 min, 95°C for 10 min and 40 cycles of
95°C for 15 s and 60°C for 1 min. All samples were ampliﬁed in
duplicate. Formation of undesired side products during PCR that
contribute to ﬂuorescence was excluded by melting curve analy-
sis after PCR. Expression difference between CD1-treated and
RML6-infected Bos2 cells for the bcl-xl gene was calculated from
PCR ampliﬁcation curves by relative quantiﬁcation using
the comparative threshold cycle (CT) method (http://docs.
appliedbiosystems.com/pebiodocs/04303859.pdf). The com-
parative CT method may be used when PCR ampliﬁcation
efficiencies for target and reference primer pairs are similar and
close to 1. This was veriﬁed by serially diluting cDNA samples,
performing qPCR with the different primer pairs and calculating
the ampliﬁcation efficiencies from the slope of the line obtained
by plotting CT values versus the logarithm of relative cDNA
concentrations.
Immunohistochemistry
Brain samples were obtained at different time points after infec-
tion and ﬁxed in 4% paraformaldehyde (PFA) for 24–72 h, inac-
tivated for 1 h with 98% formic acid, again ﬁxed for 24–72 h with
PFA and embedded in paraffin. All tissue sections were stained
with haematoxylin-eosin. Immunohistochemistry was carried out
as described earlier (Olschlager et al., 2004). Brieﬂy, a cleaved
caspase-3-speciﬁc antibody was used in a 1/200 dilution. A
cleaved caspase-9 antibody was used at 1/1000 dilution. A Bcl-
xL-speciﬁc antibody (NEB) was used in a 1/300 dilution and for
the detection of activated p65 a phospho-speciﬁc antibody [pNF-
kB(p65) NEB] at a 1/50 dilution was used. Staining reaction was
enhanced by the use of a biotinylated secondary antibody
(1/200). For detection an ABC kit was used as described by the
manufacturer (Vector). For the detection of active caspase-9 the
signal was ampliﬁed prior to substrate staining by the use of a
TSA indirect kit (Perkin Elmer).
Immunohistological quantiﬁcation
To quantify active caspase-3 and Bcl-xL reactivity the total
number of labelled cells in three different areas (1.87 mm
2)o f
midsagittal sections of three animals were counted by two inde-
pendent individuals. The three chosen areas, pons/medulla,
entorhinal cortex and cerebellum correspond to regions where
the vacuolation was found in terminally diseased mice. A total of
nine sections were quantiﬁed for each mouse strain and the
mean value and SEM was calculated and compared with the
wild-type C57Bl/6 mice in percentage of control.
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Supplementary material
The following supplementary material is available for this article
online:
Fig. S1.
Activation of caspase-9 in GT1 cells. (A) Detection of PrP
Sc in
Bos2 and GT1 cells after RML7 inoculation using the cell blot
technique as described in Mat & Met. For each experiment the
test was performed in duplicate. The circular blots before (left)
and after proteinase K treatment (right) of one representative
experiment are shown. (B) Detection of active caspase-9 in
untreated Bos2, GT1 and ScN2a cells. The active caspase stain-
ing is shown in green and the nuclear DAPI staining is shown in
blue. Cells presenting chromatin condensation are indicated with
yellow arrows. (C) Quantitative analysis of active caspase-9 in
Bos2, GT1 and ScN2A cells. Cleaved caspase-9 positive cells
were given in % of control (untreated Bos2 cells). The cells from
one of three representative experiments/50 mm
2 were counted.
Fig. S2.
Kaplan Meier curves for the onset of disease of wt, NF-kB2- and
Bcl-3-deﬁcient mice. Bcl3
-/-, Nfkb2-/-and C57/Bl6 mice as control
were inoculated intracerebrally with 30 ml of 0.2% (w/v) RML6
brain homogenate, monitored daily for clinical symptoms and
euthanized at the end point of neurological disease. First disease
symptoms were found earlier in NF-kB2- and Bcl-3 deﬁcient mice
compared to C57Bl/6 mice.
This material is available as part of the online article from
http://www.blackwell-synergy.com/doi/abs/10.1111/
j.1462-5822.2007.00950.x
Please note: Blackwell Publishing are not responsible for the
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by the authors. Any queries (other than missing material) should
be directed to the corresponding author for the article.
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